Clinical Trial Update: Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dapsone 5% gel for acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Dapsone 5% gel (dapsone)

Snippet

Sponsor: Seegpharm S.A. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED